Ranked #37 nationally and rated high-performing in leukemia, lymphoma & myeloma, colon cancer surgery, lung cancer surgery, and more.
A fully three-dimensional, high-resolution breast CT scanner, invented at the UC Davis Boone Lab, could revolutionize breast cancer detection by catching breast cancer in its earliest stages. The scanner is in the final stages of completion, and the manufacturer hopes to engage in FDA clinical trials in the next year.
UC Davis Comprehensive Cancer Center is now offering a leading-edge, outpatient, non-invasive prostate cancer procedure without a blade, an incision, a scar or radiation. It is called high-intensity focused ultrasound or (HIFU). Its use avoids the risks and the side effects that come with a radical prostatectomy while reducing time away from work or activities.
A UC Davis Health study reveals persistent racial and social disparities preventing access to autoHCT for treatment of multiple myeloma. An analysis of data from three California health care organizations, published in Clinical Lymphoma, Myeloma & Leukemia, showed that Black myeloma patients were less likely to receive autoHCT.
We welcome the opportunity to partner with you in caring for your patient.
Our specialists are available when the need arises. Learn more about a specific health specialty.
The goal of clinical studies at UC Davis Health is to discover and share knowledge to advance health.
A U.S. News & World Report best hospital in cancer, cardiology, heart & vascular surgery, diabetes & endocrinology, ENT, geriatrics, neurology & neurosurgery, orthopedics, and pulmonology & lung surgery.
The UC Davis Comprehensive Cancer Center is Sacramento’s only NCI-designated center, offering early-stage clinical trials and the latest diagnosis and treatment options. Our oncologists have extensive expertise with uncommon cancers and are highly skilled in minimally invasive techniques, including robotic-assisted surgery.
One of ~56 U.S. cancer centers designated “comprehensive” by the National Cancer Institute.
UC Davis Comprehensive Cancer Center is a member of the National Comprehensive Cancer Network, an alliance of the world’s leading cancer centers.
Cancer programs at UC Davis Comprehensive Cancer Center are accredited by the Commission on Cancer of the American College of Surgeons. Cancer programs, like those at the cancer center, voluntarily participate in the commission’s Approvals Program and meet 36 standards of quality patient care.
U.S. News & World Report rated UC Davis Medical Center high performing in treating leukemia, lymphoma & myeloma.
U.S. News & World Report rated UC Davis Medical Center high performing in colon cancer surgery.
U.S. News & World Report rated UC Davis Medical Center high performing in lung cancer surgery.
U.S. News & World Report rated UC Davis Medical Center high-performing in gynecological cancer surgery.
U.S. News & World Report rated UC Davis Medical Center high performing in prostate cancer surgery.
UC Davis Medical Center received Healthgrades® America’s 100 Best Hospitals Award for 2024, placing us among the top 2% of hospitals nationwide for overall clinical performance. We also received accolades for high-quality patient care, known as Specialty Excellent Awards, in five areas including cardiac, neurosciences, gastrointestinal, critical care and pulmonary specialties.
UC Davis Medical Center has been recognized as one of the nation’s top hospitals by the 2023 edition of Becker’s Hospital Review’s “Great hospitals in America” list.
UC Davis Health has earned national recognition from Becker’s for their work in cancer care. Our programs offer leading-edge clinical trials and pioneer research discoveries that expand access to care and enhance patient outcomes.
UC Davis Medical Center has received Magnet® recognition, the nation’s highest honor for nursing excellence.
Ranked Sacramento’s #1 hospital by U.S. News, and high-performing in back surgery, COPD, colon cancer surgery, gynecological cancer surgery, heart attack, heart failure, hip fracture, kidney failure, leukemia, lymphoma & myeloma, lung cancer surgery, pneumonia, prostate cancer surgery, stroke, TAVR, and gastroenterology & GI surgery.